Avidity Biosciences Executives Make Substantial Share Trades Amid Company News
ByAinvest
Friday, Aug 15, 2025 4:43 pm ET1min read
RNA--
Avidity Biosciences, Inc. (RNA) recently announced that Chief Medical Officer Hughes Steven George acquired 1,542 shares at $6.57 per share on August 13, 2025, and subsequently sold 1,542 shares at $46.66 per share on the same day. Additionally, Chief Financial Officer MacLean Michael F sold 30,914 shares at $42.73 per share on August 6, 2025. Furthermore, Chief Human Resources Officer McCarthy Teresa purchased 10,000 shares at $22.34 per share on August 15, 2025, and subsequently sold the same amount at $46.56 per share on the same day.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet